BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21038763)

  • 1. The prevalence of evidence-based substance use prevention curricula in the nation's elementary schools.
    Hanley SM; Ringwalt C; Ennett ST; Vincus AA; Bowling JM; Haws SW; Rohrbach LA
    J Drug Educ; 2010; 40(1):51-60. PubMed ID: 21038763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of effective substance use prevention curricula in U.S. middle schools.
    Ringwalt CL; Ennett S; Vincus A; Thorne J; Rohrbach LA; Simons-Rudolph A
    Prev Sci; 2002 Dec; 3(4):257-65. PubMed ID: 12458764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Students' special needs and problems as reasons for the adaptation of substance abuse prevention curricula in the nation's middle schools.
    Ringwalt C; Ennett ST; Vincus A; Simons-Rudolph A
    Prev Sci; 2004 Sep; 5(3):197-206. PubMed ID: 15470939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with adoption of evidence-based substance use prevention curricula in US school districts.
    Rohrbach LA; Ringwalt CL; Ennett ST; Vincus AA
    Health Educ Res; 2005 Oct; 20(5):514-26. PubMed ID: 15687101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of effective substance use prevention curricula in the nation's high schools.
    Ringwalt C; Hanley S; Vincus AA; Ennett ST; Rohrbach LA; Bowling JM
    J Prim Prev; 2008 Nov; 29(6):479-88. PubMed ID: 19015989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of evidence-based drug use prevention curricula in U.S. middle schools in 2005.
    Ringwalt C; Vincus AA; Hanley S; Ennett ST; Bowling JM; Rohrbach LA
    Prev Sci; 2009 Mar; 10(1):33-40. PubMed ID: 19002583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of evidence-based drug use prevention curricula in U.S. middle schools in 2008.
    Ringwalt C; Vincus AA; Hanley S; Ennett ST; Bowling JM; Haws S
    Prev Sci; 2011 Mar; 12(1):63-9. PubMed ID: 20683664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for teachers' adaptation of substance use prevention curricula in schools with non-white student populations.
    Ringwalt CL; Vincus A; Ennett S; Johnson R; Rohrbach LA
    Prev Sci; 2004 Mar; 5(1):61-7. PubMed ID: 15058914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing evidence-based substance use prevention curricula in North Carolina public school districts.
    Pankratz MM; Hallfors DD
    J Sch Health; 2004 Nov; 74(9):353-8. PubMed ID: 15656261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with fidelity to substance use prevention curriculum guides in the nation's middle schools.
    Ringwalt CL; Ennett S; Johnson R; Rohrbach LA; Simons-Rudolph A; Vincus A; Thorne J
    Health Educ Behav; 2003 Jun; 30(3):375-91. PubMed ID: 19731502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5th and 7th grade enhanced versions of the keepin' it REAL substance use prevention curriculum.
    Elek E; Wagstaff DA; Hecht ML
    J Drug Educ; 2010; 40(1):61-79. PubMed ID: 21038764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of ''No Child Left Behind'' legislation on drug prevention in US Schools.
    Cho H; Dion Hallfors D; Iritani BJ; Hartman S
    Eval Rev; 2009 Oct; 33(5):446-63. PubMed ID: 19429841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug abuse prevention curricula in public and private schools in Indiana.
    Bosworth K; Cueto S
    J Drug Educ; 1994; 24(1):21-31. PubMed ID: 8046548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol, tobacco, and other drug use prevention programs in U.S. schools: a descriptive summary.
    Kumar R; O'Malley PM; Johnston LD; Laetz VB
    Prev Sci; 2013 Dec; 14(6):581-92. PubMed ID: 23404662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of No Child Left Behind on the prevalence of evidence-based drug prevention curricula in the nation's middle schools.
    Ringwalt C; Hanley S; Ennett ST; Vincus AA; Bowling JM; Haws SW; Rohrbach LA
    J Sch Health; 2011 May; 81(5):265-72. PubMed ID: 21517866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short-term, quasi-experimental evaluation of D.A.R.E.'s revised elementary school curriculum.
    Vincus AA; Ringwalt C; Harris MS; Shamblen SR
    J Drug Educ; 2010; 40(1):37-49. PubMed ID: 21038762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of elementary school-based substance use prevention programs: identifying program attributes.
    Hopfer S; Davis D; Kam JA; Shin Y; Elek E; Hecht ML
    J Drug Educ; 2010; 40(1):11-36. PubMed ID: 21038761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is universal prevention against youths' substance misuse really universal? Gender-specific effects in the EU-Dap school-based prevention trial.
    Vigna-Taglianti F; Vadrucci S; Faggiano F; Burkhart G; Siliquini R; Galanti MR;
    J Epidemiol Community Health; 2009 Sep; 63(9):722-8. PubMed ID: 19395396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent Evaluation of Middle School-Based Drug Prevention Curricula: A Systematic Review.
    Flynn AB; Falco M; Hocini S
    JAMA Pediatr; 2015 Nov; 169(11):1046-52. PubMed ID: 26367105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensiveness of substance use prevention programs in U.S. middle schools.
    Wenter DL; Ennett ST; Ribisl KM; Vincus AA; Rohrbach L; Ringwalt CL; Jones SM
    J Adolesc Health; 2002 Jun; 30(6):455-62. PubMed ID: 12039516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.